IPS IPSOS

Ipsos strengthens its expertise in Germany with the acquisition of InMoment's Healthcare division

Ipsos strengthens its expertise in Germany with the acquisition of InMoment's Healthcare division

Ipsos strengthens its expertise in Germany with the acquisition of InMoment's Healthcare division

Paris, 7 July 2025 - , one of the world's leading market research companies, announces the acquisition of InMoment’s Healthcare division in Germany, enabling to bolster its expertise in this sector and generate further growth opportunities in the country.

Ben Page, CEO of Ipsos, stated: “We are pleased to welcome the experienced InMoment German Healthcare team to Ipsos, adding a new competence center for the Group’s Healthcare Service Line in Hamburg, complementing existing locations in Nuremberg, Munich and Frankfurt”

This acquisition will provide added value for Ipsos’ local and global clients in the pharmaceutical and MedTech sectors, who will benefit from a broader range of therapeutic area expertise and a more comprehensive methodological portfolio.

ABOUT IPSOS

Ipsos is one of the largest market research and polling companies globally, operating

in 90 markets and employing nearly 20,000 people.

Our passionately curious research professionals, analysts and scientists have built unique multi-specialist capabilities that provide true understanding and powerful insights into the actions, opinions and motivations of citizens, consumers, patients, customers or employees. Our 75 business solutions are based on primary data from our surveys, social media monitoring, and qualitative or observational techniques.

“Game Changers” – our tagline – summarizes our ambition to help our 5,000 clients navigate with confidence our rapidly changing world.

Founded in France in 1975, Ipsos has been listed on the Euronext Paris since July 1, 1999. The company is part of the SBF 120, Mid-60 indices and is eligible for the Deferred Settlement Service (SRD).

ISIN code FR0000073298, Reuters ISOS.PA, Bloomberg IPS:FP

35 rue du Val de Marne

75 628 Paris, Cedex 13 France

Tel. 00

Attachment



EN
07/07/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IPSOS

Carole Braudeau
  • Carole Braudeau

Credit Morning 07/25/2025

ELO: overview of H1 results and further details on the new financing structure|Takeover rumours around JD.com and Ceconomy become (more) concrete|Nexity reassures in H1 2025 with numerous positive signs, even though business remains weak|Entry into exclusive negotiations for the joint acquisition of the Milleis Group|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 25/07/2025

ELO : commentaires résultats S1 et précisions sur la nouvelle structure de financement|Takeover rumours around JD.com and Ceconomy become (more) concrete|Nexity rassure au S1 2025 avec de nombreux signaux positifs, même si l’activité reste faible|Entrée en négociations exclusives en vue de l’acquisition conjointe du Groupe Milleis|

Emmanuel Matot
  • Emmanuel Matot
 PRESS RELEASE

Ipsos: Return to organic growth in the second quarter in an environmen...

Ipsos: Return to organic growth in the second quarter in an environment that remains volatile Return to organic growth in the second quarter in an environment that remains volatile Paris, 23 July 2025 – , one of the world’s leading market research companies, achieved a revenue of €1,155.0 million in the first half of 2025. Total growth stands at 1.5%, including -0.5% organic growth, 3.1% scope effect mainly related to the acquisition of infas (leader in market research in the German public sector), and -1.1% unfavourable currency effects, due notably to the depreciation of the dollar ove...

 PRESS RELEASE

Ipsos : Retour à la croissance organique au deuxième trimestre dans un...

Ipsos : Retour à la croissance organique au deuxième trimestre dans un environnement toujours volatil Retour à la croissance organique au deuxième trimestre dans un environnement toujours volatil Paris, 23 juillet 2025 – , l’une des principales sociétés mondiales d’études de marché, a réalisé un chiffre d’affaires de 1 155,0 millions d’euros au premier semestre 2025. La croissance s’établit à 1,5 %, dont -0,5 % en organique, 3,1 % d’effet de périmètre lié principalement à l’acquisition d’infas (leader des études de marché dans le secteur public allemand) et -1,1 % d’effets de change défa...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch